A Randomized, Double-Blinded, Active-Controlled, Dose Ra

Project: Research project

Project Details

Description

A RANDOMIZED, DOUBLE-BLINDED, ACTIVE-CONTROLLED, DOSE RANGING STUDY OF CB-183,315 IN PATIENTS WITH CLOSTRIDIUM DIFFICILE INFECTION
StatusActive
Effective start/end date1/29/1012/31/20

Funding

  • Cubist Pharmaceuticals, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.